SENS
Senseonics Holdings, Inc.
NasdaqGSUSDEQUITY
Healthcare
DELAYED
Strong buy
+62/100
Last price
9.96
▼ 0.35 (3.39%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
10.16
Prev close
10.31
Day high
10.55
Day low
9.87
Volume
568.65K
Market cap
$526.63M
P/E (TTM)
—
52W range
4.79 – 10.64
Day trading desk
Gap from prior close
-1.45%
Prior close 10.31
VWAP
10.02
-0.64% from price
Relative volume
1.58×
Unusually busy
Session range
8.19%
9.75 – 10.55
Position in range
26%
Near session low
ATR (14D)
0.49
4.96% of price
Prior day high
10.36
PDH
Prior day low
9.59
PDL
Bid / ask spread
—
Quote not published
Session volume
1.07M
Avg 677.08K
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
-0.90%
-2.8%
1M
+3.43%
+2.3%
3M
+87.57%
+83.1%
6M
+47.34%
+29.2%
YTD
+80.43%
+66.2%
1Y
+7.56%
-8.9%
3Y
-17.55%
-99.8%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on SENS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
0
Net selling
Buy transactions
0
0 shares
Sell transactions
0
—
Net transactions
0
Buys less sells
Sell : buy shares
—
Not enough filings
Insider-held shares
5.21M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Aug 19, 26 | ROEDER DOUGLAS A Director |
BUY | 13.95K | $125.30K | Direct |
| Jul 1, 26 | STEVEN EDELMAN VICTOR Director |
STOCK | 2.40K | $12.88K | Direct |
| Jul 1, 26 | FIORENTINO EDWARD J Director |
STOCK | 2.63K | $14.12K | Direct |
| Jul 1, 26 | ROEDER DOUGLAS A Director |
STOCK | 2.75K | $14.74K | Direct |
| Jul 1, 26 | PRINCE DOUGLAS S Director |
STOCK | 1.51K | $8.12K | Direct |
| May 21, 26 | FIORENTINO EDWARD J Director |
STOCK | 9.85K | $0 | Direct |
| May 20, 26 | DEFALCO STEPHEN PAUL Director |
STOCK | 9.85K | $0 | Direct |
| May 20, 26 | STEVEN EDELMAN VICTOR Director |
STOCK | 9.85K | $0 | Direct |
| May 20, 26 | LARKIN SHARON DENISE Director |
STOCK | 9.85K | $0 | Direct |
| May 20, 26 | ROEDER DOUGLAS A Director |
STOCK | 9.85K | $0 | Direct |
| May 20, 26 | PRINCE DOUGLAS S Director |
STOCK | 9.85K | $0 | Direct |
| May 19, 26 | KAUFMAN FRANCINE Officer and Director |
STOCK | 63.18K | $0 | Direct |
| May 19, 26 | SULLIVAN FREDERICK T Chief Financial Officer |
STOCK | 90.25K | $0 | Direct |
| May 19, 26 | HANSEN BRIAN B Officer and Director |
STOCK | 90.25K | $0 | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
DEFALCO STEPHEN PAUL |
Director | 111.02K | Stock Award(Grant) |
FIORENTINO EDWARD J |
Director | 85.97K | Stock Award(Grant) |
GOODNOW TIMOTHY TODD |
Chief Executive Officer | 1.18M | Stock Award(Grant) |
HANSEN BRIAN B |
Officer and Director | 132.36K | Stock Award(Grant) |
HORTON KENNETH L |
General Counsel | 295.06K | Stock Award(Grant) |
JAIN MUKUL |
Chief Operating Officer | 517.06K | Stock Award(Grant) |
KAUFMAN FRANCINE |
Officer and Director | 181.07K | Stock Award(Grant) |
ROEDER DOUGLAS A |
Director | 171.19K | Purchase |
STEVEN EDELMAN VICTOR |
Director | 91.08K | Stock Award(Grant) |
SULLIVAN FREDERICK T |
Chief Financial Officer | 231.87K | Stock Award(Grant) |
Fundamentals
Market cap$526.63M
Enterprise value$446.78M
Revenue (TTM)$48.55M
Gross profit$26.64M
EBITDA$-106.51M
Net income$-109.39M
EPS (TTM)$-2.23
Free cash flow$-59.24M
Total cash$142.66M
Total debt$62.82M
Book value / share$1.71
Shares outstanding52.87M
Float43.60M
Short % of float9.81%
Dividend yield0.00%
Beta (5Y)1.03
Valuation & profitability ratios
Trailing P/E—
Forward P/E-5.09
PEG ratio—
Price / sales—
Price / book5.83
EV / revenue9.20
EV / EBITDA-4.20
Gross margin54.87%
Operating margin-248.48%
Profit margin-225.34%
Return on equity-118.24%
Return on assets-41.41%
Debt / equity69.56
Current ratio6.75
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Total revenue | $35.26M | $22.47M | $22.39M | $16.39M | +56.9% |
| Operating revenue | $35.26M | $22.47M | $22.39M | $16.39M | +56.9% |
| Cost of revenue | $19.49M | $21.94M | $19.30M | $13.66M | -11.1% |
| Gross profit | $15.76M | $533.00K | $3.09M | $2.73M | +2,857.4% |
| Research & development | $31.59M | $41.14M | $48.75M | $39.72M | -23.2% |
| Selling, general & admin | $52.51M | $34.23M | $29.94M | $31.63M | +53.4% |
| Total operating expense | $84.10M | $75.38M | $78.69M | $71.35M | +11.6% |
| Operating income | -$68.34M | -$74.84M | -$75.60M | -$68.63M | +8.7% |
| Net interest income | -$753.00K | -$3.94M | -$5.75M | -$16.88M | +80.9% |
| Pre-tax income | -$69.11M | -$78.62M | -$60.39M | $142.12M | +12.1% |
| Net income | -$69.11M | -$78.62M | -$60.39M | $142.12M | +12.1% |
| Net income to common | -$69.11M | -$78.62M | -$60.39M | $142.12M | +12.1% |
| Basic EPS | -1.66 | -2.50 | -0.11 | 0.30 | +33.6% |
| Diluted EPS | -1.66 | -2.50 | -0.11 | -0.11 | +33.6% |
| EBIT | -$64.16M | -$70.18M | -$49.28M | $160.82M | +8.6% |
| EBITDA | -$62.65M | -$68.70M | -$48.01M | $161.81M | +8.8% |
| Basic shares | 41.73M | 629.72M | 567.97M | 467.95M | -93.4% |
| Diluted shares | 41.73M | 629.72M | 567.97M | 618.21M | -93.4% |
| Line item | 2025 | 2024 | 2023 | 2022 | 2021 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $40.23M | $74.60M | $75.71M | $35.79M | — | -46.1% |
| Cash & short-term investments | $94.03M | $74.60M | $109.46M | $144.01M | — | +26.1% |
| Accounts receivable | $12.12M | $6.29M | $4.53M | $2.45M | — | +92.8% |
| Inventory | $6.70M | $4.42M | $8.78M | $7.31M | — | +51.6% |
| Total current assets | $117.53M | $91.44M | $130.03M | $161.20M | — | +28.5% |
| Property, plant & equipment | $3.75M | $3.59M | $1.18M | $1.11M | — | +4.5% |
| Goodwill & intangibles | $447.11K | $481.92K | $0 | — | — | -7.2% |
| Total assets | $126.27M | $100.44M | $138.22M | $177.67M | — | +25.7% |
| Total current liabilities | $24.35M | $38.85M | $17.26M | $31.47M | — | -37.3% |
| Current debt | — | $20.14M | — | $15.58M | $2.93M | — |
| Long-term debt | $35.59M | $34.70M | $41.20M | $56.38M | — | +2.5% |
| Total debt | $41.37M | $61.05M | $47.78M | $75.38M | — | -32.2% |
| Total liabilities | $65.22M | $116.99M | $102.42M | $180.25M | — | -44.3% |
| Retained earnings | -$1.02B | -$947.87M | -$869.26M | -$808.87M | — | -7.3% |
| Shareholder equity | $61.05M | -$16.55M | $35.80M | -$2.58M | — | +468.7% |
| Working capital | $93.19M | $52.59M | $112.77M | $129.73M | — | +77.2% |
| Net tangible assets | $60.60M | -$17.04M | $35.80M | -$2.58M | — | +455.7% |
| Shares issued | 41.27M | 595.35M | 530.36M | 479.64M | — | -93.1% |
| Line item | 2025 | 2024 | 2023 | 2022 | YoY |
|---|---|---|---|---|---|
| Net income | -$69.11M | -$78.62M | -$60.39M | $142.12M | +12.1% |
| Depreciation & amortisation | $1.51M | $1.48M | $1.28M | $985.00K | +2.5% |
| Stock-based compensation | $10.15M | $9.22M | $8.67M | $8.62M | +10.1% |
| Change in working capital | -$3.28M | $865.00K | -$3.97M | -$2.47M | -479.0% |
| Operating cash flow | -$59.13M | -$60.47M | -$70.16M | -$66.31M | +2.2% |
| Capital expenditure | -$1.12M | -$2.24M | -$350.00K | -$312.00K | +50.2% |
| Investing cash flow | -$53.42M | $32.84M | $89.71M | $26.88M | -262.7% |
| Financing cash flow | $78.19M | $26.83M | $20.37M | $41.76M | +191.4% |
| Free cash flow | -$60.24M | -$62.70M | -$70.51M | -$66.62M | +3.9% |
| End cash position | $40.55M | $74.91M | $75.71M | $35.79M | -45.9% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | YoY |
|---|---|---|---|---|---|---|---|
| Total revenue | $14.48M | $11.71M | $14.26M | $8.10M | $6.65M | — | +23.7% |
| Operating revenue | $14.48M | $11.71M | $14.26M | $8.10M | $6.65M | — | +23.7% |
| Cost of revenue | $5.92M | $4.77M | $6.59M | $4.63M | $3.53M | — | +24.2% |
| Gross profit | $8.56M | $6.94M | $7.67M | $3.47M | $3.12M | — | +23.3% |
| Research & development | $11.64M | $8.61M | $8.82M | $7.76M | $7.71M | — | +35.2% |
| Selling, general & admin | $32.91M | $30.18M | $19.77M | $15.31M | $9.73M | — | +9.1% |
| Total operating expense | $44.55M | $38.79M | $28.59M | $23.07M | $17.44M | — | +14.9% |
| Operating income | -$35.99M | -$31.85M | -$20.93M | -$19.60M | -$14.32M | — | -13.0% |
| Net interest income | -$568.00K | -$450.00K | $108.00K | $65.00K | -$172.00K | — | -26.2% |
| Pre-tax income | -$36.70M | -$32.33M | -$20.82M | -$19.53M | -$14.50M | — | -13.5% |
| Net income | -$36.70M | -$32.33M | -$20.82M | -$19.53M | -$14.50M | — | -13.5% |
| Net income to common | -$36.70M | -$32.33M | -$20.82M | -$19.53M | -$14.50M | — | -13.5% |
| Basic EPS | -0.63 | -0.71 | — | -0.43 | -0.36 | -0.02 | +11.3% |
| Diluted EPS | -0.63 | -0.71 | — | -0.43 | -0.36 | -0.02 | +11.3% |
| EBIT | -$35.10M | -$31.14M | -$19.62M | -$18.36M | -$13.36M | — | -12.7% |
| EBITDA | -$34.56M | -$30.60M | -$19.23M | -$17.98M | -$12.99M | — | -12.9% |
| Basic shares | 57.84M | 45.82M | — | 44.95M | 813.36M | 718.88M | +26.2% |
| Diluted shares | 57.84M | 45.82M | — | 44.95M | 813.36M | 718.88M | +26.2% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $44.75M | $29.61M | $40.23M | $34.46M | $31.52M | +51.1% |
| Cash & short-term investments | $142.66M | $64.32M | $94.03M | $110.95M | $126.41M | +121.8% |
| Accounts receivable | $10.27M | $14.71M | $12.12M | $7.20M | $5.16M | -30.2% |
| Inventory | $8.46M | $8.31M | $6.70M | $6.32M | $4.71M | +1.8% |
| Total current assets | $166.46M | $92.28M | $117.53M | $131.28M | $141.59M | +80.4% |
| Property, plant & equipment | $3.52M | $3.71M | $3.75M | $3.21M | $3.50M | -5.2% |
| Goodwill & intangibles | $800.00K | $435.04K | $447.11K | $800.00K | $455.00K | +83.9% |
| Total assets | $176.84M | $102.86M | $126.27M | $139.92M | $150.27M | +71.9% |
| Total current liabilities | $24.68M | $26.32M | $24.35M | $21.07M | $14.78M | -6.3% |
| Long-term debt | $55.81M | $35.91M | $35.59M | $35.27M | $35.23M | +55.4% |
| Total debt | $61.84M | $43.14M | $41.37M | $41.16M | $41.24M | +43.4% |
| Total liabilities | $86.52M | $68.52M | $65.22M | $61.76M | $55.55M | +26.3% |
| Retained earnings | -$1.09B | -$1.05B | -$1.02B | -$996.16M | -$976.63M | -3.5% |
| Shareholder equity | $90.31M | $34.34M | $61.05M | $78.17M | $94.72M | +163.0% |
| Working capital | $141.78M | $65.96M | $93.19M | $110.20M | $126.81M | +115.0% |
| Net tangible assets | $89.51M | $33.90M | $60.60M | $77.36M | $94.27M | +164.1% |
| Shares issued | 52.86M | 41.80M | 41.27M | 40.81M | 814.58M | +26.5% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | -$36.70M | -$32.33M | -$20.82M | -$19.53M | -$14.50M | -13.5% |
| Depreciation & amortisation | $548.00K | $545.00K | $382.00K | $376.00K | $370.00K | +0.6% |
| Stock-based compensation | $3.57M | $2.28M | $2.63M | $2.79M | $2.89M | +56.8% |
| Change in working capital | $1.70M | -$2.72M | -$781.00K | $525.00K | $1.76M | +162.4% |
| Operating cash flow | -$30.14M | -$32.02M | -$17.96M | -$15.82M | -$9.27M | +5.9% |
| Capital expenditure | -$217.00K | -$111.00K | -$394.00K | -$164.00K | -$124.00K | -95.5% |
| Investing cash flow | -$63.38M | $18.00M | $22.64M | $18.89M | -$69.63M | -452.2% |
| Financing cash flow | $108.66M | $3.41M | $1.10M | -$134.00K | $71.11M | +3,089.2% |
| Free cash flow | -$30.36M | -$32.14M | -$18.36M | -$15.98M | -$9.39M | +5.5% |
| End cash position | $45.07M | $29.93M | $40.55M | $34.77M | $31.83M | +50.6% |
Options analytics
Put / call volume
0.10
Call-heavy session
Put / call open interest
—
Positioning, not flow
Max pain
2.50
-74.9% from spot
ATM implied vol
1.6%
Nearest strike to spot
Skew (10% OTM)
-1.6%
Calls bid over puts
Call volume
180
Contracts, this expiry
Put volume
18
Contracts, this expiry
Heaviest call OI
2.50
0 contracts
Heaviest put OI
2.50
21 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | -0.62 | -0.63 | -1.3% |
| Mar 2026 | -0.70 | -0.71 | -1.1% |
| Dec 2025 | -0.43 | -0.46 | -6.1% |
| Sep 2025 | -0.40 | -0.43 | -6.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | -0.53 | 6 | $16.20M | +100.1% |
| Next quarter | -0.46 | 6 | $21.85M | +52.8% |
| Current year | -2.29 | 6 | $64.24M | +82.2% |
| Next year | -1.95 | 6 | $99.98M | +55.6% |
Analyst targets & ownership
Mean target$14.20
High target$18.00
Low target$8.00
Implied upside42.57%
Analyst count5
ConsensusBUY
Strong buy / Buy0 / 4
Hold2
Sell / Strong sell0 / 1
Held by insiders9.86%
Held by institutions39.64%
Institutions holding148
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
10.05
-0.88% from price
SMA 20
9.62
+3.57% from price
SMA 50
8.56
+16.41% from price
SMA 100
7.27
+36.91% from price
SMA 200
7.01
+42.09% from price
EMA 12
9.92
+0.39% from price
EMA 26
9.52
+4.67% from price
EMA 50
8.77
+13.58% from price
RSI (14)
57.7
Neutral
MACD (12,26,9)
0.41
Hist -0.05
ATR (14)
0.49
4.96% of price
Realised vol 30D
42.4%
Annualised
Bollinger upper
10.73
20, 2σ
Bollinger lower
8.51
20, 2σ
50 / 200 cross
Golden
8.56 vs 7.01
Trend bias
Above 200
+42.09%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
2.19
More volatile than market
Correlation to SPY
0.35
Loosely linked
Realised vol 30D
42.4%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-57.0%
Peak to trough
Max drawdown 5Y
-93.8%
Peak to trough
ATR 14
0.49
4.96% of price
Beta (reported)
1.03
5Y monthly, from filing
Short interest
Shares short
5.05M
Prior 5.85M
Change vs prior
-13.6%
Shorts covering
% of float
9.81%
Normal
% of shares out
9.56%
Against total outstanding
Days to cover
7.8
Crowded exit
Float
43.60M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Jul 15, 26 | Mizuho | MAINTAINED | Outperform | Outperform |
| May 12, 26 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| May 11, 26 | Stifel | MAINTAINED | Hold | Hold |
| Nov 6, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 5, 25 | TD Cowen | MAINTAINED | Buy | Buy |
| Nov 5, 25 | Barclays | MAINTAINED | Overweight | Overweight |
| Aug 27, 25 | Barclays | INITIATED | — | Overweight |
| Jul 15, 25 | TD Cowen | INITIATED | — | Buy |
| Jul 8, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Apr 10, 25 | Mizuho | INITIATED | — | Outperform |
| Mar 5, 25 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
| Nov 15, 24 | HC Wainwright & Co. | MAINTAINED | Buy | Buy |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split1:20
Split dateOct 20, 2025
SEC filings
Periodic Financial Reports
10-Q · 2026-08-06
Corporate Changes & Voting Matters
8-K · 2026-06-08
Specialized Disclosure Report filed pursuant to Section 1502 of the Dodd-Frank Wall Street Reform and Consumer Protection Act relating to the use of conflict minerals (Rule 13p-1)
SD · 2026-06-01
Offering Registrations
S-8 · 2026-05-20
Periodic Financial Reports
10-Q · 2026-05-07
Corporate Changes & Voting Matters
8-K · 2026-05-04
Proxy Statements
DEFR14A · 2026-04-09
Annual Report to Shareholders
ARS · 2026-04-06
Headlines
Beta Bionics Stock Down Despite iLet-Eversense 365 Integration Deal
Zacks · 8d ago
Beta Bionics, Senseonics Partner to Integrate Diabetes Devices
MT Newswires · 15d ago
Senseonics, Beta Bionics Partner on Eversense 365-iLet Diabetes System
MT Newswires · 23d ago
Senseonics Announces Strategic Partnership with Beta Bionics to Integrate Eversense® 365 with the iLet® Bionic Pancreas
GlobeNewswire · 23d ago
Senseonics To Participate in Upcoming Institutional Investor Conferences
GlobeNewswire · 27d ago
Sensirion Holding AG (XSWX:SENS) (H1 2026) Earnings Call Highlights: Broad-Based Growth and ...
GuruFocus.com · 43d ago
Is DXCM Stock Worth Buying as Growth Improves but Valuation Stretches?
Zacks · 55d ago
Senseonics Holdings, Inc. Common Stock Q2 Earnings Call Highlights
MarketBeat · 61d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.